Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Hung-Jen Tang and Wen-Chien Ko.
Connection Strength

2.549
  1. Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae Bacteremia. Clin Ther. 2019 10; 41(10):1996-2007.
    View in: PubMed
    Score: 0.209
  2. Short versus long duration antimicrobial treatment for community-onset bacteraemia: A propensity score matching study. Int J Antimicrob Agents. 2019 Aug; 54(2):176-183.
    View in: PubMed
    Score: 0.206
  3. Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia. J Clin Med. 2018 Dec 03; 7(12).
    View in: PubMed
    Score: 0.199
  4. Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy. J Microbiol Immunol Infect. 2019 Apr; 52(2):225-232.
    View in: PubMed
    Score: 0.199
  5. Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan. Infect Drug Resist. 2018; 11:1197-1203.
    View in: PubMed
    Score: 0.195
  6. Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremia. Int J Antimicrob Agents. 2017 Sep; 50(3):371-376.
    View in: PubMed
    Score: 0.181
  7. Propensity-matched analysis of the impact of extended-spectrum ß-lactamase production on adults with community-onset Escherichia coli, Klebsiella species, and Proteus mirabilis bacteremia. J Microbiol Immunol Infect. 2018 Aug; 51(4):519-526.
    View in: PubMed
    Score: 0.181
  8. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia. Crit Care. 2017 May 26; 21(1):119.
    View in: PubMed
    Score: 0.179
  9. Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity. Front Microbiol. 2017; 8:884.
    View in: PubMed
    Score: 0.179
  10. Salvage therapy with intravenous fosfomycin plus ceftriaxone for necrotizing fasciitis caused by penicillin-nonsusceptible Streptococcus pneumoniae. J Microbiol Immunol Infect. 2018 Aug; 51(4):573-574.
    View in: PubMed
    Score: 0.174
  11. Clinical predictors of the leading pathogens in human immunodeficiency virus-infected adults with community-onset bacteremia in the emergency department: The importance of transmission routes. J Microbiol Immunol Infect. 2018 Jun; 51(3):392-400.
    View in: PubMed
    Score: 0.174
  12. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar; 55(3):105924.
    View in: PubMed
    Score: 0.054
  13. Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). Infect Drug Resist. 2019; 12:627-640.
    View in: PubMed
    Score: 0.051
  14. Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016. Infect Drug Resist. 2019; 12:545-552.
    View in: PubMed
    Score: 0.051
  15. Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects. Front Microbiol. 2018; 9:2888.
    View in: PubMed
    Score: 0.050
  16. Implementation of a national quality improvement program to enhance hand hygiene in nursing homes in Taiwan. J Microbiol Immunol Infect. 2019 Apr; 52(2):345-351.
    View in: PubMed
    Score: 0.049
  17. Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan. PLoS One. 2018; 13(3):e0194149.
    View in: PubMed
    Score: 0.047
  18. Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan. PLoS One. 2017; 12(10):e0186338.
    View in: PubMed
    Score: 0.046
  19. Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014. J Microbiol Immunol Infect. 2019 Aug; 52(4):612-619.
    View in: PubMed
    Score: 0.046
  20. Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up. PLoS One. 2017; 12(6):e0179870.
    View in: PubMed
    Score: 0.045
  21. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents. 2012 Jun; 40 Suppl:S37-43.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.